291 related articles for article (PubMed ID: 21623854)
21. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
Arends NJ; Boonstra VH; Hokken-Koelega AC
Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
[TBL] [Abstract][Full Text] [Related]
22. Influence of growth hormone (GH) receptor deletion of exon 3 and full-length isoforms on GH response and final height in patients with severe GH deficiency.
Räz B; Janner M; Petkovic V; Lochmatter D; Eblé A; Dattani MT; Hindmarsh PC; Flück CE; Mullis PE
J Clin Endocrinol Metab; 2008 Mar; 93(3):974-80. PubMed ID: 18029459
[TBL] [Abstract][Full Text] [Related]
23. Impact of the exon 3-deleted growth hormone (GH) receptor polymorphism on baseline height and the growth response to recombinant human GH therapy in GH-deficient (GHD) and non-GHD children with short stature: a systematic review and meta-analysis.
Wassenaar MJ; Dekkers OM; Pereira AM; Wit JM; Smit JW; Biermasz NR; Romijn JA
J Clin Endocrinol Metab; 2009 Oct; 94(10):3721-30. PubMed ID: 19584188
[TBL] [Abstract][Full Text] [Related]
24. Thyroid function in short children born small-for-gestational age (SGA) before and during GH treatment.
de Kort SW; Willemsen RH; van der Kaay DC; van Dijk M; Visser TJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Aug; 69(2):318-22. PubMed ID: 18221400
[TBL] [Abstract][Full Text] [Related]
25. Relationship between nocturnal growth hormone concentrations, serum IGF-I/IGFBP-3 levels, insulin sensitivity and GH receptor allelic variant in small for gestational age children.
Mericq V; Román R; Iñiguez G; Angel B; Salazar T; Avila A; Perez-Bravo F; Cassorla F
Horm Res; 2007; 68(3):132-8. PubMed ID: 17347571
[TBL] [Abstract][Full Text] [Related]
26. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight.
Di Cesare Merlone A; Bozzola E; Castelnovi C; Chiabotto P; Costante L; De Sanctis L; Tinelli C; Bozzola M
Horm Res; 2005; 63(2):102-6. PubMed ID: 15767761
[TBL] [Abstract][Full Text] [Related]
27. [Analysis of the influencing factors of recombinant human growth hormone effect in the children with Turner syndrome].
Li J; Wu W; Liang Y; Luo XP
Zhonghua Er Ke Za Zhi; 2018 Nov; 56(11):866-870. PubMed ID: 30392213
[No Abstract] [Full Text] [Related]
28. The common exon 3 polymorphism of the growth hormone receptor gene and the effect of growth hormone therapy on growth in Korean patients with Turner syndrome.
Ko JM; Kim JM; Cheon CK; Kim DH; Lee DY; Cheong WY; Kim EY; Park MJ; Yoo HW
Clin Endocrinol (Oxf); 2010 Feb; 72(2):196-202. PubMed ID: 19681916
[TBL] [Abstract][Full Text] [Related]
29. A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone.
Dos Santos C; Essioux L; Teinturier C; Tauber M; Goffin V; Bougnères P
Nat Genet; 2004 Jul; 36(7):720-4. PubMed ID: 15208626
[TBL] [Abstract][Full Text] [Related]
30. GH treatment and its effect on bone mineral density, bone maturation and growth in short children born small for gestational age: 3-year results of a randomized, controlled GH trial.
Arends NJ; Boonstra VH; Mulder PG; Odink RJ; Stokvis-Brantsma WH; Rongen-Westerlaken C; Mulder JC; Delemarre-Van de Waal H; Reeser HM; Jansen M; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2003 Dec; 59(6):779-87. PubMed ID: 14974922
[TBL] [Abstract][Full Text] [Related]
31. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age.
Hokken-Koelega A; van Pareren Y; Arends N
Horm Res; 2005; 64 Suppl 3():95-9. PubMed ID: 16439851
[TBL] [Abstract][Full Text] [Related]
32. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
Ballerini MG; Domené HM; Scaglia P; Martínez A; Keselman A; Jasper HG; Ropelato MG
Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
[TBL] [Abstract][Full Text] [Related]
33. d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.
Montefusco L; Filopanti M; Ronchi CL; Olgiati L; La-Porta C; Losa M; Epaminonda P; Coletti F; Beck-Peccoz P; Spada A; Lania AG; Arosio M
Clin Endocrinol (Oxf); 2010 May; 72(5):661-7. PubMed ID: 20447065
[TBL] [Abstract][Full Text] [Related]
34. Intermittent recombinant growth hormone treatment in short children born small for gestational age: four-year results of a randomized trial of two different treatment regimens.
Simon D; Leger J; Fjellestad-Paulsen A; Crabbé R; Czernichow P;
Horm Res; 2006; 66(3):118-23. PubMed ID: 16772718
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone receptor exon 3 isoforms and their implication in growth disorders and treatment.
Jorge AA; Arnhold IJ
Horm Res; 2009 Apr; 71 Suppl 2():55-63. PubMed ID: 19407498
[TBL] [Abstract][Full Text] [Related]
36. Common polymorphisms of the growth hormone (GH) receptor do not correlate with the growth response to exogenous recombinant human GH in GH-deficient children.
Pilotta A; Mella P; Filisetti M; Felappi B; Prandi E; Parrinello G; Notarangelo LD; Buzi F
J Clin Endocrinol Metab; 2006 Mar; 91(3):1178-80. PubMed ID: 16394090
[TBL] [Abstract][Full Text] [Related]
37. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
[TBL] [Abstract][Full Text] [Related]
38. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
Barbosa EJ; Palming J; Glad CA; Filipsson H; Koranyi J; Bengtsson BA; Carlsson LM; Boguszewski CL; Johannsson G
J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
[TBL] [Abstract][Full Text] [Related]
39. The distribution of exon 3-deleted/full-length growth hormone receptor polymorphism in the Turkish population.
Baş F; Keleşoğlu F; Timirci Ö; Kabataş Eryılmaz S; Bozkurt N; Küçükemre Aydın B; Bundak R; Isbir T; Darendeliler F
J Clin Res Pediatr Endocrinol; 2011; 3(3):126-31. PubMed ID: 21911325
[TBL] [Abstract][Full Text] [Related]
40. Genetic and epigenetic variability in the gene for IGFBP-3 (IGFBP3): correlation with serum IGFBP-3 levels and growth in short children born small for gestational age.
van der Kaay DC; Hendriks AE; Ester WA; Leunissen RW; Willemsen RH; de Kort SW; Paquette JR; Hokken-Koelega AC; Deal CL
Growth Horm IGF Res; 2009 Jun; 19(3):198-205. PubMed ID: 18929499
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
